Publications
- Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis2022 | Faculty of Medicine in Pilsen
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine
- Long-term management of oral cladribine treatment in multiple sclerosis2021 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Early diagnosis and treatment of multiple sclerosis2021 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Commentary : Sustained reduction in disability progression in patients with primary progressive multiple sclerosis - follow-up study ORATORIO2020 | Faculty of Medicine in Pilsen
- Long-term safety of ocrelizumab in the treatment of multiple sclerosis2020 | Faculty of Medicine in Pilsen
- Escalation vs. induction therapy in multiple sclerosis2017 | Faculty of Medicine in Pilsen
- Management of multiple sclerosis2017 | Faculty of Medicine in Pilsen
- A study presented at the Congress of the American Academy of Neurology in 20162016 | Faculty of Medicine in Pilsen
- Depression and treatment with beta-interferon in multiple sclerosis2014 | Faculty of Medicine in Pilsen
Loading network view...